Improvement of participation rate in colorectal cancer (CRC) screening by training general practitioners in motivational interviewing (AmDepCCR).
CRC screening
Early detection
Motivational interviewing
Primary care
Professional-patient relations
Psychological approach
Study protocol
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
14 Feb 2022
14 Feb 2022
Historique:
received:
11
05
2021
accepted:
27
01
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
17
2
2022
Statut:
epublish
Résumé
Colorectal cancer (CRC) is the second leading cause of cancer death in France (17,712 annual deaths). However, this cancer is preventable in the majority of cases by the early detection of adenomas. In France, the organized screening for CRC relies on general practitioners (GPs). The tests delivered by the GPs are carried out in 89% of cases. However, GPs do not systematically offer the test, because of time management and communication. AmDepCCR is a cluster randomized trial. Patients are prospectively included by their GPs. The study is designed in 2 phases for the GPs: first, GPs who have never participated in motivational interviewing (MI) training will be recruited then randomly split in 2 groups. Secondly, a 6-day motivational interviewing training will be carried out for the intervention group. Then, patients will be included in both groups during a period of 1 year. The primary outcome will be the number of CRC screenings achieved in each group and its difference. The secondary outcome will be the reluctance to screening and the patient's self-estimated life expectancy at 0, 6, 12, and 24 months using the Health Belief Model (HBM). This study will help to know if GPs motivational interviewing is useful to improve organized CRC screening. In addition, it may help to improve communication between patients and GPs. GPs will be able to improve their practice in other fields of application through motivational interviewing (other screenings, addictions…). 2019-A01776-51 NCT04492215 .
Sections du résumé
BACKGROUND
BACKGROUND
Colorectal cancer (CRC) is the second leading cause of cancer death in France (17,712 annual deaths). However, this cancer is preventable in the majority of cases by the early detection of adenomas. In France, the organized screening for CRC relies on general practitioners (GPs). The tests delivered by the GPs are carried out in 89% of cases. However, GPs do not systematically offer the test, because of time management and communication.
METHODS
METHODS
AmDepCCR is a cluster randomized trial. Patients are prospectively included by their GPs. The study is designed in 2 phases for the GPs: first, GPs who have never participated in motivational interviewing (MI) training will be recruited then randomly split in 2 groups. Secondly, a 6-day motivational interviewing training will be carried out for the intervention group. Then, patients will be included in both groups during a period of 1 year. The primary outcome will be the number of CRC screenings achieved in each group and its difference. The secondary outcome will be the reluctance to screening and the patient's self-estimated life expectancy at 0, 6, 12, and 24 months using the Health Belief Model (HBM).
DISCUSSION
CONCLUSIONS
This study will help to know if GPs motivational interviewing is useful to improve organized CRC screening. In addition, it may help to improve communication between patients and GPs. GPs will be able to improve their practice in other fields of application through motivational interviewing (other screenings, addictions…).
TRIAL REGISTRATION
BACKGROUND
2019-A01776-51 NCT04492215 .
Identifiants
pubmed: 35164836
doi: 10.1186/s13063-022-06056-8
pii: 10.1186/s13063-022-06056-8
pmc: PMC8842548
doi:
Banques de données
ClinicalTrials.gov
['NCT04492215']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
144Informations de copyright
© 2022. The Author(s).
Références
Cancer Nurs. 2007 May-Jun;30(3):178-85
pubmed: 17510580
Sante Publique. 2013 Nov-Dec;25(6):775-83
pubmed: 24451423
Br J Gen Pract. 2002 Jun;52(479):526-7
pubmed: 12051237
J Community Health. 2015 Oct;40(5):975-83
pubmed: 25850386
BMC Fam Pract. 2014 Apr 11;15:66
pubmed: 24720686
Psychol Men Masc. 2014 Jan;15(1):90-94
pubmed: 25484627
J Clin Oncol. 2005 Mar 1;23(7):1548-54
pubmed: 15735130
Fam Pract. 2013 Jun;30(3):332-40
pubmed: 23221102
Arch Intern Med. 2005 Mar 28;165(6):661-6
pubmed: 15795343
Eur J Cancer Care (Engl). 2016 Jan;25(1):18-26
pubmed: 25851842
Cancer. 2010 Apr 1;116(7):1664-73
pubmed: 20143439
Ann Behav Med. 2017 Jun;51(3):327-336
pubmed: 27822612
J Clin Oncol. 2005 Dec 1;23(34):8877-83
pubmed: 16314648
Med Care. 2010 Oct;48(10):900-6
pubmed: 20808257
Health Promot Perspect. 2015 Oct 25;5(3):169-75
pubmed: 26634194
BMC Fam Pract. 2014 Apr 17;15:70
pubmed: 24742032
Lancet. 2014 Apr 26;383(9927):1490-1502
pubmed: 24225001
J Med Screen. 2017 Mar;24(1):12-19
pubmed: 27216771
Health Care Financ Rev. 2006 Spring;27(3):25-35
pubmed: 17290646
J Am Board Fam Med. 2016 Sep-Oct;29(5):533-42
pubmed: 27613786
Endoscopy. 2013;45(1):51-9
pubmed: 23212726
Patient Educ Couns. 2012 Apr;87(1):62-6
pubmed: 21873018
Eur J Gen Pract. 2013 Sep;19(3):150-7
pubmed: 24024485
BMC Cancer. 2010 Jul 06;10:355
pubmed: 20602807
Patient Educ Couns. 2016 Jun;99(6):944-52
pubmed: 26699083